• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Pfizer

Pfizer

Pfizer Inc PFE

Last Price$33.35Day Change (%)-0.33%
Open Price$33.38Day Change ($)-0.11
Day Range33.17–33.4452-Week Range29.83–37.39

As of Mon 7/24/2017 2:16:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among ...

    Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients

  2. Global Clostridium Difficile Treatment Market to Grow at a CAGR of 5.14% During 2017-2021: Key Vendors are Actelion Pharmaceuticals, Merck, Pfizer & Summit Therapeutics - Research and Markets

    Global Clostridium Difficile Treatment Market to Grow at a CAGR of 5.14% During 2017-2021: Key Vendors are Actelion Pharmaceuticals, Merck, Pfizer & Summit Therapeutics - Research and Markets

  3. UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

    UPDATE: Bipartisan political squabbling over drug prices has already cost biotech companies $21 billion

  4. 4D Molecular Therapeutics and Foundation Fighting Blindness Partner to Develop Gene Therapies for Retinal Diseases

    4D Molecular Therapeutics and Foundation Fighting Blindness Partner to Develop Gene Therapies for Retinal Diseases

12345

©2017 Morningstar Advisor. All right reserved.